Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Anemia Associated With Myelodysplastic Syndrome With a Del(5)(q31-33) Abnormality.
Clinical trial NCT00812968 · COMPLETED
Trial details
- NCT number
- NCT00812968
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2010-09-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.